Cargando…

LRRK2 Phosphorylation, More Than an Epiphenomenon

Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene are linked to autosomal dominant Parkinson's disease (PD), and genetic variations at the LRRK2 locus are associated with an increased risk for sporadic PD. This gene encodes a kinase that is physiologically multiphosphorylated, includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchand, Antoine, Drouyer, Matthieu, Sarchione, Alessia, Chartier-Harlin, Marie-Christine, Taymans, Jean-Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308437/ https://www.ncbi.nlm.nih.gov/pubmed/32612495 http://dx.doi.org/10.3389/fnins.2020.00527

Ejemplares similares

Alpha-Synuclein and Lipids: The Elephant in the Room?
por: Sarchione, Alessia, et al.
Publicado: (2021)

A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively
por: Marchand, Antoine, et al.
Publicado: (2022)

Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells
por: Goveas, Liesel, et al.
Publicado: (2021)

PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2
por: Civiero, Laura, et al.
Publicado: (2017)

GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2
por: Blanca Ramírez, Marian, et al.
Publicado: (2017)

Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkers
por: Taymans, Jean-Marc, et al.
Publicado: (2023)

The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease
por: Rideout, Hardy J., et al.
Publicado: (2020)

Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
por: Sejwal, Kushal, et al.
Publicado: (2017)

Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s Disease
por: Coku, Ilda, et al.
Publicado: (2022)

Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism
por: Taymans, Jean-Marc, et al.
Publicado: (2014)

In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2
por: Vancraenenbroeck, Renée, et al.
Publicado: (2014)

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation
por: Madero-Pérez, Jesús, et al.
Publicado: (2018)

Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients
por: Fernández, Belén, et al.
Publicado: (2019)

LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
por: Taymans, Jean-Marc, et al.
Publicado: (2011)

Is Bodily Experience an Epiphenomenon of Multisensory Integration and Cognition?
por: Baumard, Josselin, et al.
Publicado: (2019)

The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation
por: Kumar, Azad, et al.
Publicado: (2010)

LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
por: Taymans, Jean-Marc, et al.
Publicado: (2016)

Self-Regulation of Blood Oxygenation Level Dependent Response: Primary Effect or Epiphenomenon?
por: Caria, Andrea
Publicado: (2016)

Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
por: Lobbestael, E., et al.
Publicado: (2016)

Pathogenic LRRK2 requires secondary factors to induce cellular toxicity
por: Lobbestael, Evy, et al.
Publicado: (2020)

Perspective on the current state of the LRRK2 field
por: Taymans, Jean-Marc, et al.
Publicado: (2023)

The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo
por: Cresto, Noémie, et al.
Publicado: (2021)

COVID toes: Phenomenon or epiphenomenon?
por: Deutsch, Alana, et al.
Publicado: (2020)

Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice
por: Cuvelier, Elodie, et al.
Publicado: (2018)

LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status
por: Reynolds, April, et al.
Publicado: (2014)

A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
por: Kuhlmann, Naila, et al.
Publicado: (2020)

Life Is Simple—Biologic Complexity Is an Epiphenomenon
por: Torday, John S.
Publicado: (2016)

From Epiphenomenon to Biologically Important Phenomena
por: Corr, Philip J, et al.
Publicado: (2018)

Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms
por: Malik, Asad U., et al.
Publicado: (2021)

Fetal microchimerism, pregnancy epiphenomenon or kinship indicator?
por: Burton, Graham J.
Publicado: (2023)

Autophagy and LRRK2 in the Aging Brain
por: Albanese, Federica, et al.
Publicado: (2019)

“LRRK2: Autophagy and Lysosomal Activity”
por: Madureira, Marta, et al.
Publicado: (2020)

Upregulation of LRRK2 following traumatic brain injury does not directly phosphorylate Thr(175) tau
por: Donison, Neil, et al.
Publicado: (2023)

Specialty Grand Challenge for Molecular Signalling and Pathways in Molecular Neuroscience
por: Taymans, Jean-Marc
Publicado: (2021)

Role of LRRK2 in the regulation of dopamine receptor trafficking
por: Rassu, Mauro, et al.
Publicado: (2017)

ATXN2 a culprit with multiple facets
por: Nkiliza, Aurore, et al.
Publicado: (2017)

Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics
por: Kelly, Kaela, et al.
Publicado: (2020)

Modeling Parkinson’s disease in LRRK2 rodents
por: Domenicale, Chiara, et al.
Publicado: (2023)

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
por: Beccano-Kelly, Dayne A., et al.
Publicado: (2014)

Leucine-Rich Repeat Kinase 2 (LRRK2) Stimulates IL-1β-Mediated Inflammatory Signaling through Phosphorylation of RCAN1
por: Han, Kyung A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nu7j7ognplmrpfiudfh3m974s6